跳至主要内容
临床试验/NCT04445116
NCT04445116撤回不适用

A Study of Endeavor™, a Video-Game Based Cognitive Remediation, in the Pediatric Multiple Sclerosis (MS) Population

NYU Langone Health2 个研究点 分布在 1 个国家开始时间: 2023年1月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Percent compliance for total at-home sessions

研究概览

简要总结

This study will examine the feasibility of using an Endeavor™ application as a treatment modality for cognitive impairments in the pediatric MS population. Participants will be asked to undergo a hour-long baseline evaluation, followed by at-home Endeavor™ application sessions. Subjects will complete the User Experience Feedback Form weekly on REDCap and at the end of the study. They will undergo another hour-long follow-up evaluation at the end of the study.

详细描述

Duration of subject participation in this study is anticipated to take 3-4 months. After consent/assent, participants will complete an one hour-long baseline study visit in-person at the MSCCC, or through a video visit. During this visit, participants will complete a neuropsychological evaluation and baseline study surveys and get trained on the use of the Endeavor™ video game. Participants will then be instructed to target a completion of at-home game play 5 days a week, for a total period of 8 weeks, using their own iOS mobile device, or a study-provided device if needed, approximately 25-30 minutes each day. Subjects will be instructed to complete the User Experience Feedback Form weekly via REDCap to assess feasibility and acceptability of Endeavor™. At the conclusion of participation, participants will complete an hour long neuropsychological evaluation and end of study User Experience Feedback Form via REDCap (in-person at the MSCCC, or through a telehealth video visit).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 22 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age at enrollment: 12 years 0 months to 22 years 11 months
  • Confirmed Diagnosis of Multiple Sclerosis with onset < 17 years and 11 months (defined by the 2013 International Pediatric MS Study Group (IPMSSG) criteria (Krupp, Tardieu, Amato, Banwell, Chitnis, Dale, Ghezzi, Hintzen, Kornberg, Pohl, Rostasy, Tenembaum, Wassmer, & Sclerosis, 2013) and the 2010 McDonald criteria (Polman et al., 2011).)
  • Followed at NYU Langone Health MSCCC
  • Expanded Disability Status Scale (EDSS) score of ≤3.5

排除标准

  • Previous report of an IQ < 70
  • Non-English speaking, learned English in the past three years, or learned English after the age of 12 years
  • Neurological disorder (other than MS) with potential to significantly influence cognition (e.g. head injury)
  • Other serious chronic or unstable medical condition (e.g., epilepsy, sickle cell disease, Type 1 diabetes)
  • Not willing to comply with all study procedures
  • Insufficient visual and motor ability to carry out academic and cognitive tests
  • Relapse ≤ 2months prior to academic and cognitive data collection
  • Steroid treatment ≤ 1 month prior to academic and cognitive data collection

结局指标

主要结局

Percent compliance for total at-home sessions

时间窗: End of study (Day 60)

Participants will be categorized as "compliant" if they interact with the mobile Endeavor™ a minimum of 3 times per week for a minimum of six of the eight weeks across the study period of 60 days.

次要结局

  • Change in Fatigue in Adult participants(Baseline (Day 0), End of study (Day 60))
  • Change in Fatigue in Pediatric participants(Baseline (Day 0), End of study (Day 60))
  • Change in Quality of life in Participants(Baseline (Day 0), End of study (Day 60))
  • Change in behaviors in pediatric participants.(Baseline (Day 0), End of study (Day 60))
  • Change in Depression in Participants(Baseline (Day 0), End of study (Day 60))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验